International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 3 , Pages 661-668 , 1 July 2011

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

  • Shu-Zhen Lai, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Wen-Fei Li, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Lei Chen, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Wei Luo, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Yuan-Yuan Chen, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Li-Zhi Liu, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Imaging Diagnosis and Interventional Center, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Ying Sun, M.D, Ph.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Ai-Hua Lin, M.D., Ph.D.

      Affiliations

    • Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Meng-Zhong Liu, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • ,
  • Jun Ma, M.D.

      Affiliations

    • State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, Guangzhou, People's Republic of China
    • Corresponding Author InformationReprint requests to: Jun Ma, M.D., State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Cancer Center, Sun Yat-Sen University, 651 Dongfeng Road East, Guangzhou 510060, People's Republic of China. Tel: 86-20-87343469; Fax: 86-20-87343295

Received 2 November 2009 ,Revised 10 March 2010 ,Accepted 10 March 2010.

References 

  1. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–1450
  2. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22
  3. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study of disease control and preservation of salivary function. Cancer. 2004;101:1584–1593
  4. Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57–62
  5. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107–1116
  6. Al-Sarraf M, LeBlanc M, Giri PGS, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099. J Clin Oncol. 1998;16:1310–1317
  7. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook: From the AJCC cancer staging manual. 6th ed.. New York: Springer; 2002;
  8. Ma J, Mai H, Hong MH, et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol. 2001;19:1350–1357
  9. Zhao C, Han F, Lu LX, et al. Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma. Ai Zheng. 2004;23:1532–1537
  10. Tsao SY. Technical details for radiotherapy delivery. In:  van Hasselt CA,  Gibb AG editor. Nasopharyngeal carcinoma. Hong Kong: Chinese University Press; 1991;p. 207–208
  11. Liang SB, Sun Y, Liu LZ, et al. Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. Int J Radiat Oncol Biol Phys. 2009;75:742–750
  12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53:457–481
  13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187–220
  14. Marks JE, Bedwinek JM, Lee F, et al. Dose-response analysis for nasopharyngeal carcinoma: An historical perspective. Cancer. 1982;50:1042–1050
  15. Teo PM, Leung SF, Lee WY, et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: The existence of a dose-tumor control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys. 2000;46:445–458
  16. Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:1046–1054
  17. Hara W, Loo BW, Goffinet DR, et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2008;71:393–400
  18. Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64(2):374–381
  19. Lee AW, Ng WT, Hung WM, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys. 2009;73:1121–1128
  20. Moench HC, Philips TL. Carcinoma of the nasopharynx: Review of 146 patients with emphasis on radiation dose and time factors. Am J Surg. 1972;124:515–518
  21. Chow E, Payne D, Keane T, et al. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 1997;39:149–154
  22. Fang FM, Tsai WL, Go SF, et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50:961–969
  23. Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys. 1991;21:549–556
  24. Chang JT, Chan SC, Yen TC, et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005;62:501–507
  25. Roychowdhury DF, Tseng A, Fu KK, et al. New prognostic factors in nasopharyngeal carcinoma. Cancer. 1996;77:1419–1426
  26. Hui EP, Ma BB, Leung SF, et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 2009;27:242–249
  27. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;272:131–146
  28. Johnson CR, Thames HD, Huang DT, et al. The tumor volume and clonogen number relationship: Tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys. 1995;332:281–287
  29. Lartigau E, Le Ridant AM, Lambin P, et al. Oxygenation of head and neck tumors. Cancer. 1993;717:2319–2325
  30. Okunieff P, Hoeckel M, Dunphy EP, et al. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993;26:631–636
  31. Curran D, Giralt J, Harari PM, et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol. 2007;25:2191–2197

 Shu-Zhen Lai and Wen-Fei Li contributed equally to this work.

 This work was supported by grants from the Science Foundation of Key Hospital Clinical Program of Ministry of Health, P.R. China (no. 2007-353), the Hi-Tech Research and Development Program of China (no. 2006AA02AA404), the International Cooperation Foundation of Guangdong Science and Technology Department of China (no. 2008B050100039), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (no. 20090171110077).

 Conflicts of interest: none.

PII: S0360-3016(10)00459-1

doi: 10.1016/j.ijrobp.2010.03.024

International Journal of Radiation Oncology * Biology * Physics
Volume 80, Issue 3 , Pages 661-668 , 1 July 2011

Article Tools

* Image Usage & Resolution